Association of mitotic checkpoint regulator MAD2L1 with fibrosis progression in chronic hepatitis C patients

Saira S. Khalid; Ayman A. Abdo; Waleed Al-hamoudi; Khalid Alswat

doi:10.1016/j.clinre.2022.101860

Back

Association of mitotic checkpoint regulator MAD2L1 with fibrosis progression in chronic hepatitis C patients

Journal article

Peer reviewed

Association of mitotic checkpoint regulator MAD2L1 with fibrosis progression in chronic hepatitis C patients

Saira S. Khalid, Ayman A. Abdo, Waleed Al-hamoudi and Khalid Alswat

Clinics and research in hepatology and gastroenterology, Vol.46(4), pp.101860-101860

01/04/2022

DOI: https://doi.org/10.1016/j.clinre.2022.101860

PMID: 34999251

Abstract

Cell cycle inhibitors

Cell cycle proteins

Chronic hepatitis C

Hepatitis C virus

microRNAs

Mitosis regulator

•Differential miRNAs expression can help in investigating disrupted target proteins.•Overexpression of p27 and MAD2L1 proteins in hepatitis C patients.•Significant association of MAD2L1 overexpression with fibrosis progression.

Metrics

1 Record Views

Details

Title: Association of mitotic checkpoint regulator MAD2L1 with fibrosis progression in chronic hepatitis C patients
Creators - without role: Saira S. Khalid - King Saud University
Ayman A. Abdo - King Saud University
Waleed Al-hamoudi - King Saud Medical City
Khalid Alswat - King Saud University
Publication Details: Clinics and research in hepatology and gastroenterology, Vol.46(4), pp.101860-101860
Publisher: Elsevier Masson SAS
Identifiers: 9945928908331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article